Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             343 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A clinical and laboratory scoring system for DIC in the field of obstetrics Terao, T.
1986
41 S1 p. 155-
1 p.
artikel
2 A comparison of the surface expression of platelet fibrinogen with the binding of plasma fibrinogen to activated platelets Legrand, C.
1986
41 S1 p. 71-
1 p.
artikel
3 Activation and desensitization of the endoperoxide/thromboxane platelet receptor 1986
41 S1 p. 15-
1 p.
artikel
4 Activation and inhibition of platelet aggregation by two distinct anti-human platelet monoclonal antibodies 1986
41 S1 p. 61-
1 p.
artikel
5 Acute hypoxemia due to respiratory insufficiency does not increase blood fibrinolytic activity Stegnar, M.
1986
41 S1 p. 111-
1 p.
artikel
6 Adhesive protein interaction with platelets 1986
41 S1 p. 7-
1 p.
artikel
7 Adhesive proteins and their receptors 1986
41 S1 p. 123-
1 p.
artikel
8 A human, heat-treated thrombin preparation for clinical and technical use Feldman, P.A.
1986
41 S1 p. 36-
1 p.
artikel
9 Alteration of von Willebrand factor (vWF) subunit composition in factor VIII concentrates 1986
41 S1 p. 103-
1 p.
artikel
10 A method for high resolution study of the mechanisms of blood flow in small blood vessels 1986
41 S1 p. 47-
1 p.
artikel
11 A new case of severe homozygote congenital factor VII deficiency 1986
41 S1 p. 38-
1 p.
artikel
12 A new clinically applicable technique for the direct measurement of white cell rheology 1986
41 S1 p. 47-
1 p.
artikel
13 A new experimental model of venous thrombosis in the rats Millet, J.
1986
41 S1 p. 81-
1 p.
artikel
14 A new ion-exchange procedure for the preparation of prothrombin complex concentrate Feldman, P.A.
1986
41 S1 p. 36-
1 p.
artikel
15 An integrated scheme for the purification of glycoproteins GP Ib, IIb, IIIa and IV from human platelets 1986
41 S1 p. 70-
1 p.
artikel
16 A novel method to differentiate cell adhesion and aggregation of whole blood on extracellular matrix seeded with endothelial cells Eisert, W.G.
1986
41 S1 p. 44-
1 p.
artikel
17 Antibodies to phospholipids prevent collagen-induced thromboxane B2 formation and platelet aggregation 1986
41 S1 p. 78-
1 p.
artikel
18 Anticoagulant treatment of pregnant women with a lupus anticoagulant (LA) 1986
41 S1 p. 76-
1 p.
artikel
19 Antiplatelets antibodies in systemic lupus erythematosus (S.L.E.) Kaplan, C.
1986
41 S1 p. 23-
1 p.
artikel
20 Antiplatelet treatment (Ditazol) in the bladder cancer 1986
41 S1 p. 143-
1 p.
artikel
21 Antithrombin III and protein C in retinal vein thrombosis 1986
41 S1 p. 59-
1 p.
artikel
22 Antithrombin III measurement in serum and plasma by laser nephelometry may lead to controversial results Hopmeier, P.
1986
41 S1 p. 50-
1 p.
artikel
23 Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties 1986
41 S1 p. 148-
1 p.
artikel
24 Anti-Xa plasma activity in liver cirrhosis:Relation with antithrombin III and alpha1-antitripsin Cordova, C.
1986
41 S1 p. 52-
1 p.
artikel
25 A passive platelet-fibrin interaction 1986
41 S1 p. 166-
1 p.
artikel
26 A plasmin-like, neutral, calcium dependent protease is responsible for the loss of the high molecular weight (HMW) multimers in the carbohydrate (CHO) modified von Willebrand factor (VWF) Federici, A.B.
1986
41 S1 p. 140-
1 p.
artikel
27 Application of a photometric fibrinogen assay to automated kinetic analyzers 1986
41 S1 p. 30-
1 p.
artikel
28 Arterial microfibrils thrombogenicity : Involvement of a thrombospondin-like structure 1986
41 S1 p. 55-
1 p.
artikel
29 A simple experimental model of thrombolysis in the rat: Effect of urokinase and streptokinase Bernat, A.
1986
41 S1 p. 112-
1 p.
artikel
30 Aspirin insensitive ATP-secretion occurs as an initial response at platelet collagen contact Malmgren, Rigmor
1986
41 S1 p. 166-
1 p.
artikel
31 Assay for activated protein C using a photometric apit test 1986
41 S1 p. 137-
1 p.
artikel
32 Association nifedipine-dipiridamol on platelets in ischemic heart disease 1986
41 S1 p. 141-
1 p.
artikel
33 A study of the anti-thrombotic potential of a low molecular weight heparin fragment CY222 given intravenously to normal volunteers Johnston, R.V.
1986
41 S1 p. 75-
1 p.
artikel
34 Author index 1986
41 S1 p. 175-191
17 p.
artikel
35 Behaviour of factor XIII subunits in neoplasm 1986
41 S1 p. 41-
1 p.
artikel
36 Binding of heparin to endothelial cells van Rijn, J.L.M.L.
1986
41 S1 p. 93-
1 p.
artikel
37 Bleeding and antithrombotic effects of a low molecular weight heparin (LMW/OP 2123) Parma, B.
1986
41 S1 p. 95-
1 p.
artikel
38 Blood coagulation changes in patients with acute lymphoblastic leukemia (all) treated with L-asparaginase 1986
41 S1 p. 40-
1 p.
artikel
39 Blood component treatment for haemostasis Bloom, A.L.
1986
41 S1 p. 13-
1 p.
artikel
40 Calcium protects the IIb-IIIa complex from chymotrypsin degradation McGregor, J.L.
1986
41 S1 p. 70-
1 p.
artikel
41 Ca2+ liberation by IP3: Mechanism of regulation Enouf, J.
1986
41 S1 p. 8-
1 p.
artikel
42 Can low dose heparin be helpful in the prevention of active angina? Neri Serneri, G.G.
1986
41 S1 p. 161-
1 p.
artikel
43 Cation complexation at the antithrombin-binding site may differ from that occurring in other parts of heparin 1986
41 S1 p. 92-
1 p.
artikel
44 Cellular elements of blood and fibrin network structure Nair, C.H.
1986
41 S1 p. 32-
1 p.
artikel
45 Characterization of fibrinogen Barcelona 1 (FB): Congenital dysfibrinogenemia with defective release of fibrinopeptide A and abnormal plasmic degradation Vila, V.
1986
41 S1 p. 31-
1 p.
artikel
46 Characterization of human protein S Bouma, B.N.
1986
41 S1 p. 135-
1 p.
artikel
47 Characterization of monoclonal antibodies against antithrombin III 1986
41 S1 p. 51-
1 p.
artikel
48 Characterization of platelets from a patient showing a lack of fibrinogen binding but aggregating to thrombin and collagen McGregor, J.L.
1986
41 S1 p. 26-
1 p.
artikel
49 Chemical cross-linking of human α-thrombin to platelet membrane receptors 1986
41 S1 p. 72-
1 p.
artikel
50 Chemically induced venous thrombosis of esophageal varices is not accompanied with changes in hemostatic parameters 1986
41 S1 p. 80-
1 p.
artikel
51 Chemically modified heparins of defined structure Moffat, C.F
1986
41 S1 p. 92-
1 p.
artikel
52 Clinical and laboratory studies on patients with lupus anticoagulant 1986
41 S1 p. 97-
1 p.
artikel
53 Clinical pharmacology of a new preparation of low molecular weight heparin Palareti, G.
1986
41 S1 p. 68-
1 p.
artikel
54 Clinical trials with low-molecular weight heparin in venous thrombosis 1986
41 S1 p. 67-
1 p.
artikel
55 Coagulation disturbances and their prognostic significance in lung cancer patients Ponahajba, A.
1986
41 S1 p. 158-
1 p.
artikel
56 Coagulation with copper and vitamin C 1986
41 S1 p. 31-
1 p.
artikel
57 Combination of stimuli and/or inhibitors in the regulation of platelet function 1986
41 S1 p. 14-
1 p.
artikel
58 Comparative evaluation of 3 automated coagulation instruments Houbouyan, L.L.
1986
41 S1 p. 34-
1 p.
artikel
59 Comparative pharmacokinetics of a low molecular weight heparin (LHN-1, NOVO) and conventional heparin after intravenous injection 1986
41 S1 p. 89-
1 p.
artikel
60 Comparison of human umbilical artery and rabbit abdominal aorta as substrata to study thrombus formation in flowing blood Bastida, E.
1986
41 S1 p. 134-
1 p.
artikel
61 Comparison of protein C assays 1986
41 S1 p. 162-
1 p.
artikel
62 Conformation equilibria of the γ chain cooh-terminus of human fibrinogen 1986
41 S1 p. 5-
1 p.
artikel
63 Congenital antithrombin (AT) III deficiency - thromboprophylaxis with at III concentrate during pregnancy and delivery Tengborn, L.
1986
41 S1 p. 49-
1 p.
artikel
64 Congenital deficiency of prothrombin and stuart-prower factor Hajnž|≲ić, T.F.
1986
41 S1 p. 37-
1 p.
artikel
65 Construction of a full-length von Willebrand factor (VWF) cDNA Verweij, C.L.
1986
41 S1 p. 138-
1 p.
artikel
66 Contribution of heparin endothelial cell binding to its inactivation Bârzu, T.
1986
41 S1 p. 116-
1 p.
artikel
67 Contributions of molecular biology to the study of hemostasis 1986
41 S1 p. 65-
1 p.
artikel
68 Controlled clinical trial of ticlopidine in patients suffering from intermittent claudication Arcan, J.C.
1986
41 S1 p. 159-
1 p.
artikel
69 Covalent crosslinking of factor V by megakaryocyte transglutaminase and factor XIIa 1986
41 S1 p. 35-
1 p.
artikel
70 Covalent hybrid plasminogen activator Robbins, K.C.
1986
41 S1 p. 19-
1 p.
artikel
71 Critical review of clinical trials with: rt-PA 1986
41 S1 p. 128-
1 p.
artikel
72 CY 216, new low molecular weight heparin fraction : Antithrombotic properties in experimental models and in clinical trials Frapaise, F.X.
1986
41 S1 p. 96-
1 p.
artikel
73 Decrease of clumping of platelets and red cells, from patients with heart disease or cancer, uner zero gravity 1986
41 S1 p. 171-
1 p.
artikel
74 Deep vein thrombosis and asymptomatic pulmonary embolism Monreal, M.
1986
41 S1 p. 80-
1 p.
artikel
75 Demonstration of hypercoagulability during contraceptive drug treatment Inauen, W.
1986
41 S1 p. 114-
1 p.
artikel
76 Demostration of hipercoagulability in patients with mediterranean spotted fever Vicente, V.
1986
41 S1 p. 156-
1 p.
artikel
77 Detection of lupus anticoagulant in patients under oral anticoagulant treatment 1986
41 S1 p. 98-
1 p.
artikel
78 Diagnosis of deep venous thrombosis : Value of real time B mode ultrasound imaging and continuous wave doppler (echography-doppler) compared to venography 1986
41 S1 p. 75-
1 p.
artikel
79 Dipyridamole and platelet aggregation in whole blood 1986
41 S1 p. 149-
1 p.
artikel
80 Dipyridamole induced rectal bleeding Lewinski, U.H.
1986
41 S1 p. 29-
1 p.
artikel
81 Discriminant analysis and bayes' theorem in decision making for pulmonary thromboembolism Petruzzelli, S.
1986
41 S1 p. 73-
1 p.
artikel
82 Disseminated carcinomatosis of the bone marrow (DCBM) as a distinct variety of cancer metastases—with reference to disseminated intravascular coagulation (DIC) as a complication of DCBM 1986
41 S1 p. 154-
1 p.
artikel
83 Disseminated intravascular coagulation. New approaches to diagnosis and treatment Preston, F.E.
1986
41 S1 p. 12-
1 p.
artikel
84 Dissolution of “ex vivo” thrombi by tissue plasminogen activator, streptokinase and urokinase 1986
41 S1 p. 109-
1 p.
artikel
85 Diurnal fluctuation of tissue plasminogen activator: Effects of recumbency and parenteral nutrition Keber, D.
1986
41 S1 p. 109-
1 p.
artikel
86 Do changes in the haemostatic system reflect the presence and/or the extent of coronary sclerosis? Schmitz-Huebner, U.
1986
41 S1 p. 113-
1 p.
artikel
87 Does phlebography permit the prediction of the efficiency of the thrombolytic therapy? 1986
41 S1 p. 107-
1 p.
artikel
88 Double-blind clinical trial of ticlopidine versus placebo in peripheral atherosclerotic disease of the legs 1986
41 S1 p. 160-
1 p.
artikel
89 Early biochemical events in thrombin-induced activation of normal and pathological platelets Rendu, F.
1986
41 S1 p. 8-
1 p.
artikel
90 Early platelet-collagen interactions in whole blood studied by a new method (basic wave): Experiencies with dipiridamole ex vivo in the presence of absence of extracellular calcium 1986
41 S1 p. 14-
1 p.
artikel
91 Editorial Board 1986
41 S1 p. v-
1 p.
artikel
92 Effective lysis of old venous thrombi in the rabbit with recombinant single-chain tissue-type plasminogen activator (t-PA) Baldus, B.
1986
41 S1 p. 112-
1 p.
artikel
93 Effectiveness of longterm oral anticoagulant treatment in preventing thrombosis in hereditary protein S deficiency Michiels, J.J.
1986
41 S1 p. 136-
1 p.
artikel
94 Effect of acenocoumarol on platelet activity of patients with chronic heart disease Fernández, M.A.
1986
41 S1 p. 164-
1 p.
artikel
95 Effect of adrenoceptors on the molecular and cellular responses induced by thrombin 1986
41 S1 p. 171-
1 p.
artikel
96 Effect of BN 52021, a new PAF-receptor antagonist, on the rat tail bleeding time 1986
41 S1 p. 148-
1 p.
artikel
97 Effect of [Ca2+] in the suspending medium on the ability of von Willebrand factor and fibrinogen to support ADP-induced aggregation of human platelets 1986
41 S1 p. 121-
1 p.
artikel
98 Effect of dyslipemia associated or unassociated with acute myocardial infarction (AMI) on angor pectoris in blood filterability 1986
41 S1 p. 155-
1 p.
artikel
99 Effect of endotoxin (E) on plasma thromboxane B2 (TXB2) level and prostacyclin (PGI2) release from vessel walls, lungs and kidneys in rabbits and on human platelet function 1986
41 S1 p. 45-
1 p.
artikel
100 Effect of exhaustion on the enzymatic systems that regulate synthesis of PGI2 in rat aorta 1986
41 S1 p. 44-
1 p.
artikel
101 Effect of Formosn cobra ( Naja naja atra ) venom phospholipase A2 on platelet aggregation and blood coagulation 1986
41 S1 p. 168-
1 p.
artikel
102 Effect of haemodialysis on the prekallikrein system Alegre, A.
1986
41 S1 p. 39-
1 p.
artikel
103 Effect of pentosan-polysulfate on the haemorheological parameters in elderly patients. Possible role of leucocyte arachidonic acid metabolism Freyburger, G.
1986
41 S1 p. 46-
1 p.
artikel
104 Effect of propranolol, barbiturate anesthesia and splenectomy on factor VIIIC release induced by DDAVP. An experimental study in the dog Pina-Cabral, J.M.
1986
41 S1 p. 104-
1 p.
artikel
105 Effects of administration of ticlopidine and low dose-aspirin on platelet function in ischemic heart disease patients Strano, Antonio
1986
41 S1 p. 143-
1 p.
artikel
106 Effects of different antithrombotic (AT) agents (PGI2, heparin (H), CG 4203) on platelets and hemostasis during bicarbonate hemodialysis (HD) 1986
41 S1 p. 145-
1 p.
artikel
107 Effects of human antithrombin III (at III) and heparin on endotoxin-induced disseminated intravascular coagulation (DIC) in rabbits Rocha, E.
1986
41 S1 p. 58-
1 p.
artikel
108 Effects of OHo scavengers on platelet aggregation Violi, F.
1986
41 S1 p. 172-
1 p.
artikel
109 Efficiency of platelets radiolabelling is improved by prostacyclin 1986
41 S1 p. 167-
1 p.
artikel
110 Elisa evaluation of B-thromboglobulin and platelet factor 4 1986
41 S1 p. 170-
1 p.
artikel
111 Endothelial cell thrombospondin: Binding domains for fibronectin and heparin and Ca dependent structure 1986
41 S1 p. 54-
1 p.
artikel
112 Endothelial plasminogen activator inhibitor: A new member of the serpin gene family Pannekoek, H.
1986
41 S1 p. 20-
1 p.
artikel
113 Enzyme immunoassay for determination of human thrombin/antithrombin III complex Pelzer, H.
1986
41 S1 p. 51-
1 p.
artikel
114 Eosinophilia - a possible link to thrombosis and fibrosis Lederman, J.
1986
41 S1 p. 153-
1 p.
artikel
115 Epitopic specificity in identifying crosslinked (XL) fibrin derivatives by the monoclonal antibody (MAb) DD-3B6/22 Whitaker, A.N.
1986
41 S1 p. 6-
1 p.
artikel
116 Evaluation in whole blood of the antiplatelet activity of dipyridamol and pentoxifylline with the basix wave 1986
41 S1 p. 149-
1 p.
artikel
117 Evaluation of human thrombopoiesis by examination of marrow megakaryocytes 1986
41 S1 p. 125-
1 p.
artikel
118 Evaluation of kinetic parameters of the interaction of human plasma kallikrein with aprotonin or ARG15-aprotonin using chromogenic microtechnology 1986
41 S1 p. 16-
1 p.
artikel
119 Evaluation of labsystems FP-910 coagulation analyzer designed for clotting, chromogenic and EIA methods 1986
41 S1 p. 34-
1 p.
artikel
120 Evaluation of serial impedance-plethysmography as a single diagnostic test in deep vein-thrombosis : A prospective study 1986
41 S1 p. 74-
1 p.
artikel
121 Evaluation of the plasma kinin system in mediterranean spotted fever Vicente, V.
1986
41 S1 p. 38-
1 p.
artikel
122 Evaluation of the thromboembolic risk in hereditary quantitative and qualitative antithrombin III (at III) deficiency by measurement of plasmatic fibrin degradation products (FDF) using a monoclonal anti-D-neo antibody - role of heparan sulphates in the antithrombotic action of at III 1986
41 S1 p. 53-
1 p.
artikel
123 Evidence for two conformational forms of heparins/heparans 1986
41 S1 p. 91-
1 p.
artikel
124 Expression and biological activity of synthetic beta-thromboglobulin-related antigen 1986
41 S1 p. 170-
1 p.
artikel
125 Factor IX conversion in plasma 1986
41 S1 p. 17-
1 p.
artikel
126 Factor VIII inhibitor in mild haemophilia Capel, P.
1986
41 S1 p. 43-
1 p.
artikel
127 Factor XIII and fibronectin in nephrotic syndrome 1986
41 S1 p. 39-
1 p.
artikel
128 Factor XIII-catalyzed polymeric assemblies in platelets 1986
41 S1 p. 121-
1 p.
artikel
129 Factor XIII of blood coagulation in tumor invading macrophages. Its possible involvement in intratumoral fibrin formation 1986
41 S1 p. 40-
1 p.
artikel
130 Feedback responses to thrombocytopenia 1986
41 S1 p. 124-
1 p.
artikel
131 Fibrinolysis in pregnancy Kruithof, E.K.O.
1986
41 S1 p. 21-
1 p.
artikel
132 Fibrinolytic activity of OP/LMWH in experimental venous thrombosis Barbanti, M.
1986
41 S1 p. 87-
1 p.
artikel
133 Fibrin-specific thrombolysis with tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator 1986
41 S1 p. 127-
1 p.
artikel
134 Follow up of acute deep venous thrombosis by real time B-mode ultrasound imaging and continuous wave doppler (Echography Doppler) Elias, A
1986
41 S1 p. 81-
1 p.
artikel
135 Free radical generation and arterial disease 1986
41 S1 p. 133-
1 p.
artikel
136 Functional and antigenic protein C and its inhibitor in normal pregnancy and preeclampsia Gilabert, J.
1986
41 S1 p. 162-
1 p.
artikel
137 Functional characterization of a monoclonal anti tissue type plasminogen activator (t-PA) antibody stimulating plasminogen activator activity of t-PA Wojta, J.
1986
41 S1 p. 19-
1 p.
artikel
138 Further experience with at III substitution in shock and DIC 1986
41 S1 p. 131-
1 p.
artikel
139 α-Granule deficiency (gray platelet syndrome) discovered in an elderly patient 1986
41 S1 p. 27-
1 p.
artikel
140 Haemorheological therapy by arachidonic acid in hepatic cirrhosis Freyburger, G.
1986
41 S1 p. 46-
1 p.
artikel
141 Hemorrhagic disorders in neonates 1986
41 S1 p. 11-
1 p.
artikel
142 Heparin catabolism by human vascular endothelial cells 1986
41 S1 p. 116-
1 p.
artikel
143 Heparin-DHE 3×5000 i.U. Versus acetylsalicylic acid 3×0.5 G plus 2.5 MG DHE as prophylaxis of thromboembolism in femoral fractures near by the hip joint 1986
41 S1 p. 85-
1 p.
artikel
144 Heparin induced osteoporosis in rats 1986
41 S1 p. 86-
1 p.
artikel
145 Heparinoid ORG 10172 in patients undergoing turp: a safety, study ten Cate, H.
1986
41 S1 p. 84-
1 p.
artikel
146 Heparin pharmacokinetics in deep venous thrombosis and in chronic renal insufficiency 1986
41 S1 p. 89-
1 p.
artikel
147 Heparin structural modifications and human platelet aggregation Mastacchi, R.
1986
41 S1 p. 87-
1 p.
artikel
148 Hereditary deficiency in heparin cofactor II (HeCoFII) and the risk for the development of thrombosis Bertina, R.M.
1986
41 S1 p. 59-
1 p.
artikel
149 Hereditary warfarin resistance 1986
41 S1 p. 164-
1 p.
artikel
150 Heterogeneity in type IIB von Willebrand disease: Two unrelated cases with no family history and mild abnormalities of ristocetin-induced interaction between von Willebrand factor and platelets Federici, A.B.
1986
41 S1 p. 101-
1 p.
artikel
151 Heterogeneity of type IIA von Willebrand Disease: Studies with protease inhibitor Batlle, J.
1986
41 S1 p. 140-
1 p.
artikel
152 Heterozygous protein C deficiency 1986
41 S1 p. 63-
1 p.
artikel
153 High dose immunoglobulin (IGG) therapy for idiopathic thrombocytopenic purpura (ITP) and its functional effects on platelets Matsuda, J.
1986
41 S1 p. 11-
1 p.
artikel
154 High-dose intravenous immunoglobulin for treatment of idiopathic thrombocytopenic purpura in children Boguslawska-Jaworska, J.
1986
41 S1 p. 22-
1 p.
artikel
155 High fibrinogen level and prolonged thrombin clotting time Marongiu, F.
1986
41 S1 p. 33-
1 p.
artikel
156 Homozygous protein C deficiency Seligsohn, U.
1986
41 S1 p. 64-
1 p.
artikel
157 How many patients with acute myocardial infarction could be treated in France by intravenous streptokinase ? Results of a prospective trial (enim 84) 1986
41 S1 p. 106-
1 p.
artikel
158 Human monocyte-macrophage (M-M) procoagulant activity (PCA) 1986
41 S1 p. 43-
1 p.
artikel
159 Human platelet membrane glycoprotein I has high affinity for collagen 1986
41 S1 p. 71-
1 p.
artikel
160 Identification and characterization of a defect of a homozygous factor XI deficient patient with cross-reacting material Mannhalter, C.
1986
41 S1 p. 17-
1 p.
artikel
161 Impedance plethysmography (IPG) in the diagnosis of deep vein thrombosis (DVT) in an urban hospital setting 1986
41 S1 p. 82-
1 p.
artikel
162 Increased plasma levels of antithrombin-III (at-III) in coronary patients 1986
41 S1 p. 52-
1 p.
artikel
163 Indobufen activity on intraplatelet arachidonic acid metabolism Abbate, R.
1986
41 S1 p. 144-
1 p.
artikel
164 Induction of tolerance in four high-responding haemophiliacs with facor IX antibodies Nilsson, I.M.
1986
41 S1 p. 35-
1 p.
artikel
165 Influence of kinetics of network growth on fibrin network structure Shah, G.A.
1986
41 S1 p. 32-
1 p.
artikel
166 Influence of membrane cholesterol content on platelet procoagulant activity Zwaal, R.F.A.
1986
41 S1 p. 1-
1 p.
artikel
167 Inhibition of collagen-induced platelet activation by 5′-p-fluorosulfonylbenzoyl adenosine : Evidence for an ADP requirement and synergistic influence of prostaglandin endoperoxides 1986
41 S1 p. 62-
1 p.
artikel
168 Inhibition of experimental arterial and venous thrombosis by the novel pyridazinone-derivative, C85-3143 1986
41 S1 p. 147-
1 p.
artikel
169 Inhibition of heparitinase mediated degradation of extracellular matrix heparan sulfate by non anticoagulant heparin species 1986
41 S1 p. 117-
1 p.
artikel
170 Inhibition of human platelet function and thromboxane B2(TXB2) synthesis and prostacyclin (PGI2) release from rabbit aortic rings by nifedipine 1986
41 S1 p. 150-
1 p.
artikel
171 Inhibition of tyloxapol (triton WR 1339) enhanced venous thrombosis by low molecular weight heparin (OP 2123) Bianchini, P.
1986
41 S1 p. 94-
1 p.
artikel
172 Inhibition of von Willebrand factor binding to activated platelets by the tetrapeptide ARG-GLY-ASP-SER and the dodecapeptide of fibrinogen gamma chains 1986
41 S1 p. 139-
1 p.
artikel
173 Inhibitory effect of SIN 1 on platelet function : Possible interference with platelet phosphorylations and fibrinogen binding Weill, D.
1986
41 S1 p. 60-
1 p.
artikel
174 Interaction of actin filaments with platelet membranes 1986
41 S1 p. 7-
1 p.
artikel
175 Interaction of endothelial cells and the vessel wall 1986
41 S1 p. 122-
1 p.
artikel
176 Intraplatelet levels on von Willebrand antigen (VWAg) and fibrinogen (I) in myeloproliferative syndromes 1986
41 S1 p. 103-
1 p.
artikel
177 Intravenous thrombolytic therapy of acute myocardial infarction Seyfert, U.T.
1986
41 S1 p. 105-
1 p.
artikel
178 In vivo platelet function in diabetes mellitus Stegmann, J.A
1986
41 S1 p. 25-
1 p.
artikel
179 Is beta-thromboglobulin of prognostic value in patients with transient cerebral ischaemia ? Davi, Giovanni
1986
41 S1 p. 158-
1 p.
artikel
180 LAV/HTLV III antibodies in swedish haemophiliacs; in relation to type and dosage of factor concentrate Berntorp, E.
1986
41 S1 p. 18-
1 p.
artikel
181 Levels of platelet reactivity and patency rate of coronary bypass in a ticlopidine-placebo double blind study David, J.L.
1986
41 S1 p. 141-
1 p.
artikel
182 LMW heparin (OP 2123): In vitro and in vivo protamine interaction Bianchini, P.
1986
41 S1 p. 94-
1 p.
artikel
183 Low molecular weight heparin fractions as an alternative therapy in heparin-induced thrombocytopenia 1986
41 S1 p. 90-
1 p.
artikel
184 Lupus anticoagulant inhibits the thrombomodulin dependent activation of protein C by human endothelial cells Cariou, R.
1986
41 S1 p. 78-
1 p.
artikel
185 Lupus anticoagulant (L.A.) : Clinical features of 61 cases 1986
41 S1 p. 76-
1 p.
artikel
186 Macroglobulinemia associated with a lupus like anticoagulant and false elevated FDP level Capel, P.
1986
41 S1 p. 99-
1 p.
artikel
187 Measurement of D.Dimer with an enzyme-immuno-assay 1986
41 S1 p. 33-
1 p.
artikel
188 MEFS, mediterranean erythrocyte filtration study on essential hypertension 1986
41 S1 p. 48-
1 p.
artikel
189 Megakaryocyte colony stimulating activity (MK-CSA) and megakaryocyte progenitors (CFU-MK) in bone marrow transplantation 1986
41 S1 p. 124-
1 p.
artikel
190 Megakaryocyte - vessel wall interaction Eldor, A.
1986
41 S1 p. 122-
1 p.
artikel
191 Metabolism of antithrombin III·Protease complexes by various cells in culture 1986
41 S1 p. 129-
1 p.
artikel
192 Modulation of adhesive proteins in the matrix by endothelial cells de Groot, Philip G.
1986
41 S1 p. 123-
1 p.
artikel
193 Molecular biology of von Willebrand factor and implications for its structure-function relationships 1986
41 S1 p. 65-
1 p.
artikel
194 Molecular genetics of haemophilia 1986
41 S1 p. 66-
1 p.
artikel
195 Monitoring the therapy with antithrombin III concentrates 1986
41 S1 p. 130-
1 p.
artikel
196 Neutralization of a low molecular weight heparin (LHN-1) and conventional heparin by protamine sulphate in rats 1986
41 S1 p. 86-
1 p.
artikel
197 N-methyl-thiotetrazole cephalosporins inhibit vitamin K metabolism of coagulation proteins Mackie, I.J.
1986
41 S1 p. 42-
1 p.
artikel
198 No significant effect of chronic aspirin use on tissue plasminogen activator release during arm venous occlusion in coronary patients Keber, I.
1986
41 S1 p. 110-
1 p.
artikel
199 Occult thyrotoxicosis in patients with atrial fibrillation and secondary arterial embolism 1986
41 S1 p. 152-
1 p.
artikel
200 On the role of guanine nucleotide binding regulatory proteins (G-proteins) in signal transduction in platelets; studies with sodium fluoride (NaF) Kienast, J.
1986
41 S1 p. 120-
1 p.
artikel
201 Open problems in prevention and treatment of thromboembolism. An introduction 1986
41 S1 p. 67-
1 p.
artikel
202 Optimal dosage regimens with tissue plasminogen activator 1986
41 S1 p. 69-
1 p.
artikel
203 Partial identification of a plasmatic factor stimulating prostacyclin production in rat smooth muscle cells de Castellarnau, C.
1986
41 S1 p. 45-
1 p.
artikel
204 Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomas Kirchheimer, J.C.
1986
41 S1 p. 108-
1 p.
artikel
205 PCR 4099. A new antithrombotic drug. Evaluation of tolerance and of pharmacological activity 1986
41 S1 p. 144-
1 p.
artikel
206 Pentosane polysulfate like heparin may induce severe thrombocytopenia Le Querrec, A.
1986
41 S1 p. 90-
1 p.
artikel
207 Performances of a new clot based functional protein C assay Martinoli, J.L.
1986
41 S1 p. 163-
1 p.
artikel
208 Peripheral blood mononuclear cell fibrinolytic activity (FA) serum inhibition is reversed by both heating at 56°C and heparin Ghezzo, F.
1986
41 S1 p. 111-
1 p.
artikel
209 Peripheral vascular symptoms as the initial manifestation of thrombocythemia vera 1986
41 S1 p. 115-
1 p.
artikel
210 PGI2 platelet receptors are affected by cholesterol/phospholipid molar ratio Modesti, P.A.
1986
41 S1 p. 72-
1 p.
artikel
211 Pharmacokinetics of a low molecular weight heparin compared with standard heparin Mätzsch, T.
1986
41 S1 p. 118-
1 p.
artikel
212 Pharmacological aspects and laboratory control of thrombolytic agents 1986
41 S1 p. 127-
1 p.
artikel
213 Plasma inhibition of thromboplastin-mediated blood coagulation 1986
41 S1 p. 57-
1 p.
artikel
214 Platelet activation and bleeding time in female fawn hooded rats depending on their sexual cycle Kirchmaier, C.M.
1986
41 S1 p. 169-
1 p.
artikel
215 Platelet activity during coronary angiography 1986
41 S1 p. 24-
1 p.
artikel
216 Platelet activity in normal children and children with stroke 1986
41 S1 p. 24-
1 p.
artikel
217 Platelet aggregation in fawn hooded rats : Evidence that PCR 4099 inhibits selectively the platelet ADP pathway 1986
41 S1 p. 146-
1 p.
artikel
218 Platelet aggregation is enhanced in hypertriglyceridemias Riess, H.
1986
41 S1 p. 2-
1 p.
artikel
219 Platelet and plasma von Willebrand factor in normal and IIC von Willebrand's disease López-Fernández, M.F.
1986
41 S1 p. 100-
1 p.
artikel
220 Platelet arachidonic acid metabolism in angina pectoris Neri Serneri, G.G.
1986
41 S1 p. 160-
1 p.
artikel
221 Platelet at III in normals and in pathologic conditions 1986
41 S1 p. 129-
1 p.
artikel
222 Platelet count and platelet aggregation in inflammatory bowel disease in response to the disease activity Krause, W.H.
1986
41 S1 p. 25-
1 p.
artikel
223 Platelet function and sensitivity to prostacyclin (PGI2), platelet survival time (PST) and plasma thromboxane B2 (TXB2) level in chronic obstructive arterial disease (COAD) 1986
41 S1 p. 15-
1 p.
artikel
224 Platelet ihibitors in arterial thrombosis and atherogenesis 1986
41 S1 p. 69-
1 p.
artikel
225 Platelet mediated arteriolar smooth muscle cell proliferation and migration in erythromelalgic; thrombotic thrombocythemia vera: Ultrastructural evidence 1986
41 S1 p. 157-
1 p.
artikel
226 Platelet parameters and aggregation in essential (ET) and reactive (RT) thrombocytosis 1986
41 S1 p. 23-
1 p.
artikel
227 Platelet phospholipids in hemostasis and thrombosis Zwaal, R.F.A.
1986
41 S1 p. 10-
1 p.
artikel
228 Platelet protein S 1986
41 S1 p. 64-
1 p.
artikel
229 Platelet secretion defect and impaired synthesis or response of thromboxane A2 in a patient with a bleeding disorder de Castellarnau, C.
1986
41 S1 p. 28-
1 p.
artikel
230 Platelet subpopulations: External to invaginated plasma membrane surface area is constant, independent of size 1986
41 S1 p. 119-
1 p.
artikel
231 Platelet thrombospondin is non-thrombogenic 1986
41 S1 p. 56-
1 p.
artikel
232 Platelet-vessel wall interaction - new data 1986
41 S1 p. 122-
1 p.
artikel
233 Platelet von Willebrand factor: An important determinant of the bleeding time in type I von Willebrand's disease Gralnick, H.R.
1986
41 S1 p. 102-
1 p.
artikel
234 Positive effect on haemostasis by 1-deamino-8-D-arginine vasopressin (DDAVP) in congenital platelet function defects Schulman, S.
1986
41 S1 p. 27-
1 p.
artikel
235 Possible prevention of cardiovascular complications in patients with intermittent claudication 1986
41 S1 p. 60-
1 p.
artikel
236 Pregnancy induced hypertension and hemostasis Saleh, A.A.
1986
41 S1 p. 98-
1 p.
artikel
237 Prekallikrein, hageman factor, and high molecular weight kininogen in liver cirrhosis Cordova, C.
1986
41 S1 p. 41-
1 p.
artikel
238 Prekallikrein-kinin system in early acute myocardial infarction 1986
41 S1 p. 156-
1 p.
artikel
239 Prenatal diagnosis and carrier determination in haemophilia B using three gene-specific polymorphic DNA markers Giannelli, F.
1986
41 S1 p. 18-
1 p.
artikel
240 Prevalence of protein C (PC) and protein S (PS) deficiency in patients with thrombotic disease Broekmans, A.W.
1986
41 S1 p. 135-
1 p.
artikel
241 Prevention of aortocoronary bypass occlusion. Beneficial effects of ticlopidine on early and late patency rates of coronary bypass grafts : A double blind study 1986
41 S1 p. 62-
1 p.
artikel
242 Prevention of thrombosis in critical arterial prostheses by defibrination Dormandy, J.A.
1986
41 S1 p. 159-
1 p.
artikel
243 Prevention of thrombosis in critical arterial prostheses by lowering red cell concentration 1986
41 S1 p. 114-
1 p.
artikel
244 Procoagulant activity of a human T lymphoma cell line 1986
41 S1 p. 16-
1 p.
artikel
245 Progress in the diagnosis and treatment of acquired Von Willebrand's syndrome (AVWS) 1986
41 S1 p. 12-
1 p.
artikel
246 Properties of phospholipid bilayer membranes and their relationship to phospholipid function in blood clotting 1986
41 S1 p. 9-
1 p.
artikel
247 Prospective randomized controlled trial of intravenous streptokinase in acute myocardial infarction 1986
41 S1 p. 106-
1 p.
artikel
248 Protamine neutralization of a very low molecular weight heparin fragment CY 222 in vitro and in vivo study Doutremepuich, C.
1986
41 S1 p. 88-
1 p.
artikel
249 Protamine neutralization of the thrombolytic activity of a very low molecular weight heparin fragment (VLMW) CY 222 Vairel, E.G.
1986
41 S1 p. 88-
1 p.
artikel
250 Protein C and fibrinolisis 1986
41 S1 p. 64-
1 p.
artikel
251 Protein C and S antigens in glomerular nephropathy and nephrotic syndrome 1986
41 S1 p. 163-
1 p.
artikel
252 Protein C (PC) and coumarin-induced skin necrosis Broekmans, A.W.
1986
41 S1 p. 137-
1 p.
artikel
253 Protein S deficiency 1986
41 S1 p. 64-
1 p.
artikel
254 Protein S deficiency in 7 Austrian families 1986
41 S1 p. 136-
1 p.
artikel
255 Proteolytic degradation of fibronectin by plasmin stimulates human neutrophil degranulation 1986
41 S1 p. 56-
1 p.
artikel
256 Rapid and complete degradation of thymidine by human peripheral blood platelets: Implications for genotoxicity assays 1986
41 S1 p. 167-
1 p.
artikel
257 Reduced plasma high-density lipoprotein (HDL) and increased platelet activity in arterial vs. venous blood Aviram, M.
1986
41 S1 p. 2-
1 p.
artikel
258 Reduction of the atherosclerosis risk factors in Legazpia by an intervention trial Iriarte, J.A.
1986
41 S1 p. 157-
1 p.
artikel
259 Regulation of cell-mediated neutralization of thrombin by antithrombin III 1986
41 S1 p. 57-
1 p.
artikel
260 Relationship between fatty acid composition of platelet membrane phospholipid and phostaglandin in biosynthesis in diabetes mellitus 1986
41 S1 p. 3-
1 p.
artikel
261 Relative insensitivity of epinephrine induced platelet aggregation to prostacyclin (PGI2) 1986
41 S1 p. 169-
1 p.
artikel
262 Release of fibrinopeptides A and B and activation of factor XIII by isolated, immobilized B chain of thrombin 1986
41 S1 p. 5-
1 p.
artikel
263 Repartition of fibrinolytic abnormalities in patients with idiopathic deep vein thrombosis 1986
41 S1 p. 73-
1 p.
artikel
264 Reverse fibrin slide technique: A method for localization of plasminogen activator inhibitor activity in tissue sections Kirchheimer, J.C.
1986
41 S1 p. 108-
1 p.
artikel
265 Role of GPIIb/IIIa as well as GPIb in von Willebrand factor-mediated platelet adhesion to collagen 1986
41 S1 p. 138-
1 p.
artikel
266 Secretion of protein-kinase activity by stimulated platelets 1986
41 S1 p. 120-
1 p.
artikel
267 Segmental wall motion analysis after early intravenous urokinase in evolving myocardial infarction 1986
41 S1 p. 105-
1 p.
artikel
268 Selected hemostasis parameters and survival in burn patients DePoli, P.A.
1986
41 S1 p. 153-
1 p.
artikel
269 Sensitivity and specifity of thrombin generation and platelet secretion in patients with malignancy Scharf, R.E.
1986
41 S1 p. 115-
1 p.
artikel
270 Serum fatty acids and platelet reactivity 1986
41 S1 p. 1-
1 p.
artikel
271 Severe heparin and pentosan polysulfate - induced thrombocytopenias : Clinical aspects - in vitro effects of pentosan polysulfate, low molecular weight (LMW) heparins and oligosaccharides Borg, J.Y.
1986
41 S1 p. 96-
1 p.
artikel
272 Shear stress activation of platelets and von Willebrand's high molecular weight multimers 1986
41 S1 p. 139-
1 p.
artikel
273 Sleep dependent variations of heparin anti factor Xa plasma activity 1986
41 S1 p. 91-
1 p.
artikel
274 Some aspects of the regulation of megakaryocytopoiesis 1986
41 S1 p. 126-
1 p.
artikel
275 Spontaneous platelet aggregation, VWF-AG and fibrin as risk factors for new vascular occlusions in type I and II diabetes Breddin, H.K.
1986
41 S1 p. 154-
1 p.
artikel
276 Standardisation of the laser induced thrombosis model and evaluation of anti-thrombotic drugs Seiffge, D.
1986
41 S1 p. 113-
1 p.
artikel
277 Structural and immunological comparison of thrombospondin from platelets and colostrum 1986
41 S1 p. 55-
1 p.
artikel
278 Structural and immunological properties of myosin from human platelet external and internal membranes 1986
41 S1 p. 173-
1 p.
artikel
279 Structural requirements for the antagonism of PAF-acether induced platelet activation by triazolobenzodiazepines 1986
41 S1 p. 147-
1 p.
artikel
280 Study of blood clotting and fibrinolysis during r-TPA infusion in patients with acute myocardial infarction 1986
41 S1 p. 21-
1 p.
artikel
281 Subcellular distribution of vinculin in resting and activated platelets Muszbek, L.
1986
41 S1 p. 172-
1 p.
artikel
282 Subcutaneous enoxaparin as anticoagulant therapy in acute pulmonary embolism in man Huet, Y.
1986
41 S1 p. 79-
1 p.
artikel
283 Substitution of antithrombin III in acquired at-III deficiency Breddin, H.K.
1986
41 S1 p. 131-
1 p.
artikel
284 Substitution of antithrombin-III in patients with congenital at III-deficiency Schramm, W.
1986
41 S1 p. 130-
1 p.
artikel
285 Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. Clinical implications Altman, R.
1986
41 S1 p. 15-
1 p.
artikel
286 Synthetic heparin fragments : Tools to study the contribution of factor Xa inhibition to the antithrombotic effect Choay, J.
1986
41 S1 p. 95-
1 p.
artikel
287 The assembly of blood clotting complexes on membranes 1986
41 S1 p. 9-
1 p.
artikel
288 The basic wave: A method for studying early platelet-collagen interactions in whole blood. Study in normal and hypertriglyceridemic subjects Vallés, J.
1986
41 S1 p. 3-
1 p.
artikel
289 The case for thrombolytic therapy in deep vein thrombosis (DVT)? 1986
41 S1 p. 69-
1 p.
artikel
290 The clinical significance of measurement of platelet volume in disease 1986
41 S1 p. 125-
1 p.
artikel
291 The effect of dipyridamole and pentoxifylline on prostacyclin generation and platelet aggregation in patients with diffuse cerebrovascular insufficiency. Influence of the time of treatment 1986
41 S1 p. 142-
1 p.
artikel
292 The effect of heparin and other sulphated polysaccharides on the bleeding time: Possible relationship with lipase release 1986
41 S1 p. 117-
1 p.
artikel
293 The effect of iloprost (ZK 36,374) on white cell behaviour 1986
41 S1 p. 150-
1 p.
artikel
294 The effect of ionizing irradiation on the production of a potent neutrophil chemoattractant by cultured vascular endothelial cells 1986
41 S1 p. 133-
1 p.
artikel
295 The effect of phospholipids on purified human endothelial thrombomodulin Freyssinet, J.-M.
1986
41 S1 p. 77-
1 p.
artikel
296 The effect of plasma proteins on fibrin network structure Nair, C.H.
1986
41 S1 p. 4-
1 p.
artikel
297 The effect of transdermally applied iloprost (ZK36-374) on whole blood platelet aggregation 1986
41 S1 p. 151-
1 p.
artikel
298 The effect of zinc ions on the thrombin-binding capacity of fibrin Hopmeier, P.
1986
41 S1 p. 4-
1 p.
artikel
299 The effects of long-term cyclosporin a therapy post-renal transplantation on haemostasis Cohen, H.
1986
41 S1 p. 152-
1 p.
artikel
300 The in vivo effects of acaenocoumarol, phenprocoumon and warfarin on vitamin KO-reductase and vitamin K-dependent carboxylase activities in hepatic and non-hepatic tissues of the rat 1986
41 S1 p. 165-
1 p.
artikel
301 The prekallikrein-kinin system during deep vein thrombosis 1986
41 S1 p. 85-
1 p.
artikel
302 The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism Korninger, C.
1986
41 S1 p. 129-
1 p.
artikel
303 The prolongation of the platelet survival time mediated by ketanserin in rats 1986
41 S1 p. 61-
1 p.
artikel
304 Therapeutic range for control of oral anticoagulant therapy 1986
41 S1 p. 68-
1 p.
artikel
305 Therapy of DIC in the field of gynecology with an antithrombin III concentrate Ikenou, T.
1986
41 S1 p. 50-
1 p.
artikel
306 The reliability of APTT methods and the relationship to lipid composition and ultrastructure Stevenson, K.
1986
41 S1 p. 42-
1 p.
artikel
307 The role of aggregation and thromboxane A2 in the release of platelet alpha granules Riess, H.
1986
41 S1 p. 168-
1 p.
artikel
308 The role of cyclic nucleotides in the control of platelet aggregation in vitro and in vivo 1986
41 S1 p. 146-
1 p.
artikel
309 The role of lupus anticoagulant in habitual abortion Carp, H.J.A.
1986
41 S1 p. 97-
1 p.
artikel
310 The role of sialic acid in plasmin human fibrinogen degradation Regañon, E.
1986
41 S1 p. 30-
1 p.
artikel
311 The sensitivity of different coagulation reagents to the presence of lupus anticoagulants 1986
41 S1 p. 77-
1 p.
artikel
312 The vascular plasminogen activator activity present in human plasma after venous occlusion circulates as a vPA-inhibitor complex Boutière, B.
1986
41 S1 p. 20-
1 p.
artikel
313 Three cases of fletcher factor deficiency in an Iranian Jewish family with various allergic and/or rheumatoid features 1986
41 S1 p. 37-
1 p.
artikel
314 Thrombocytopenia associated with a Waldenstrom's IgM that binds to platelets and DNA 1986
41 S1 p. 22-
1 p.
artikel
315 Thrombolytic therapy of deep venous thrombosis (DVT) 1986
41 S1 p. 79-
1 p.
artikel
316 Thrombolytic therapy with heparin-hemoclar∗ association Pinot, J.J.
1986
41 S1 p. 107-
1 p.
artikel
317 Thrombomodulin and the activation of protein C Guillin, M.C.
1986
41 S1 p. 63-
1 p.
artikel
318 Thrombosis prophylaxis with LMW heparin and sodium heparin in patients with total hip replacement 1986
41 S1 p. 83-
1 p.
artikel
319 Thrombosis prophylaxis with low molecular weight heparin in trauma surgery 1986
41 S1 p. 84-
1 p.
artikel
320 Thrombospondin forms a surface for plasminogen activation by tissue activator: Formation of a ternary complex 1986
41 S1 p. 54-
1 p.
artikel
321 Thrombospondin inhibits adhesion of endothelial cells to substrata 1986
41 S1 p. 132-
1 p.
artikel
322 Thrombospondin macromolecular complexes 1986
41 S1 p. 7-
1 p.
artikel
323 Thromboxane, beta-thrombglobin, prostacyclin, diabetes & atherosclerosis 1986
41 S1 p. 26-
1 p.
artikel
324 Time course of the effects of some heparin(oid)s on bleeding and of the interactions of these substances with factor Xa and thrombin in rats Hobbelen, P.M.J.
1986
41 S1 p. 118-
1 p.
artikel
325 Time varying turbulent fluid characteristics and vascular endothelium Einav, S.
1986
41 S1 p. 132-
1 p.
artikel
326 Transacylase-catalyzed biosynthesis of arachidonic acid containing ether phospholipids in human platelets 1986
41 S1 p. 119-
1 p.
artikel
327 Treatment of acute thrombosis in cases of antithrombin III deficiency Tengborn, L.
1986
41 S1 p. 49-
1 p.
artikel
328 Treatment of deep vein thrombosis by a very low molecular weight heparin fragment (CY 222) : A dose range study 1986
41 S1 p. 82-
1 p.
artikel
329 Treatment of deep vein thrombosis (D.V.T.) at home, diagnosed by Impedance Plethysmography (I.P.G.), with oral anticoagulants only 1986
41 S1 p. 74-
1 p.
artikel
330 Treatment of deep vein thrombosis (DVT) with LMWH CY 222. Modifications of biological parameters Aillaud, M.F.
1986
41 S1 p. 83-
1 p.
artikel
331 Turnover of antithrombin III and heparin cofactor II in baboons treated with heparin and pentosan polysulfate 1986
41 S1 p. 58-
1 p.
artikel
332 Two new cases of congenital dysfibrinogenemia with impaired aggregation of monomers: Fibrinogens Salamanca II and Santander I Fernández, J.
1986
41 S1 p. 6-
1 p.
artikel
333 UDCG 115 a benzimidazo-pyridazinone compound with cardiovascular activity inhibits platelet thrombus formation Bastida, E.
1986
41 S1 p. 145-
1 p.
artikel
334 Ultrastructural modifications of platelet plasma-membrane in vascular disease patients and the effect of a carbochromen derivative Bianciardi, G.
1986
41 S1 p. 142-
1 p.
artikel
335 Unfractionated heparin vs low molecular weight heparin fraction (LMWH) : An experimental study during neurosurgery Huet, Y.
1986
41 S1 p. 93-
1 p.
artikel
336 Unique multimeric pattern of von Willebrand factor in a patient with a benign monoclonal gammapathy López-Fernández, M.F.
1986
41 S1 p. 101-
1 p.
artikel
337 Unresolved issues concerning thrombolytic therapy 1986
41 S1 p. 128-
1 p.
artikel
338 Uraemic plasma does not support the adhesion of normal platelets to the vessel subendothelium Castillo, R.
1986
41 S1 p. 102-
1 p.
artikel
339 Visual prognosis following treatment of central retinal vessel occlusion by streptokinase Peternel, P.
1986
41 S1 p. 110-
1 p.
artikel
340 Vitamin K-dependent carboxylase in human vessel wall 1986
41 S1 p. 134-
1 p.
artikel
341 Von Willebrand factor multimer patterns in pregnancy-induced hypertension Brenner, B.
1986
41 S1 p. 100-
1 p.
artikel
342 Whole blood thromboxane and prostacyclin production in familial hypercholesterolemia Wessels, P.
1986
41 S1 p. 29-
1 p.
artikel
343 Zinc ingestion increases platelet sensitivity 1986
41 S1 p. 28-
1 p.
artikel
                             343 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland